Showing results (91-100 of 327) with videos related to
Sort By:
Pageof 33
Clinical Pharmacology and Therapeutics|December 1, 1981
Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemiaR J Piroli, G T Passananti, C A Shively, et al.Biochemical Pharmacology|October 15, 1990
Metabolism of nicotine by hepatocytesG A Kyerematen, M Morgan, G Warner, et al.Annals of Internal Medicine|October 1, 1981
Underrepresentation of women in new drug trialsE L Kinney, J Trautmann, J A Gold, et al.Clinical Pharmacology and Therapeutics|January 1, 1975
Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunctionE S Vesell, J R Shapiro, T Passananti, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991
Nicotine metabolism in stumptailed macaques, Macaca arctoidesM Seaton, G A Kyerematen, M Morgan, et al.Clinical Pharmacology and Therapeutics|October 1, 1984
Sources of interindividual variations in acetaminophen and antipyrine metabolismR M Nash, L Stein, M B Penno, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1988
Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitroG A Kyerematen, G F Owens, B Chattopadhyay, et al.Journal of Clinical Pharmacology|December 11, 1992
Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effectsC E Chambers, E S Vesell, C Helm, et al.Clinical Pharmacology and Therapeutics|December 1, 1990
Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinineG A Kyerematen, M L Morgan, B Chattopadhyay, et al.Pageof 33